NCT04266093View on ClinicalTrials.gov

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

October 1, 2035

Study Completion Date

October 1, 2050

Conditions
Cervical Intraepithelial NeoplasiaCervical NeoplasmsOropharyngeal NeoplasmsSquamous Intraepithelial Lesions of the CervixHematologic Malignacies
Interventions
DRUG

GeneTherapy

Observation/ Gene Therapy Long-term Follow-up. Subjects who have enrolled on an applicable NCI CIO gene therapy treatment protocol.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH